Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Dec 25;105(5):e1967–e1980. doi: 10.1210/clinem/dgz306

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Endocrine Society 2019.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 5. — Circulating inflammatory markers and ex vivo cytokine production in primary aldosteronism (PA).

A, No differences between PA patients (n = 15) and essential hypertension controls (n = 15) were observed in circulating parameters of inflammation (hsCRP, IL-6, IL-18, MCP-1), plaque instability (MMP2), and endothelial dysfunction (e-selectin, VCAM, MCP-1). Ex vivo PBMCs cytokine production was comparable for B, proinflammatory, and C, anti-inflammatory, monocyte-derived cytokines after 24 hours. D, There were no differences in lymphocyte-derived cytokines.